Daito Pharmaceutical Co.,Ltd. (TYO:4577)
Japan
· Delayed Price · Currency is JPY 1,260.00
-5.00 (-0.40%)
Apr 28, 2026, 3:30 PM JST
Daito Pharmaceutical Revenue
Daito Pharmaceutical had revenue of 11.59B JPY in the quarter ending February 28, 2026, a decrease of -3.61%. This brings the company's revenue in the last twelve months to 50.77B, up 3.94% year-over-year. In the fiscal year ending May 31, 2025, Daito Pharmaceutical had annual revenue of 50.64B with 7.99% growth.
Revenue (ttm)
50.77B
Revenue Growth
+3.94%
P/S Ratio
0.72
Revenue / Employee
47.31M
Employees
1,073
Market Cap
36.34B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| May 31, 2025 | 50.64B | 3.75B | 7.99% |
| May 31, 2024 | 46.90B | 1.79B | 3.98% |
| May 31, 2023 | 45.10B | 1.64B | 3.77% |
| May 31, 2022 | 43.46B | -5.25B | -10.78% |
| May 31, 2021 | 48.71B | 3.72B | 8.27% |
| May 31, 2020 | Pro | Pro | Pro |
| May 31, 2019 | Pro | Pro | Pro |
| May 31, 2018 | Pro | Pro | Pro |
| May 31, 2017 | Pro | Pro | Pro |
| May 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Koa Shoji Holdings | 23.66B |
| Mizuho Medy | 11.26B |
| Fuji Pharma | 54.57B |
| Fuso Pharmaceutical Industries,Ltd. | 62.17B |
| Pharma Foods International | 67.84B |
| ASKA Pharmaceutical Holdings | 68.70B |
| KYORIN Pharmaceutical | 133.26B |
| Taiko Pharmaceutical | 6.40B |